Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06455787Not ApplicableRecruiting

J-Valve Transfemoral Pivotal Study

Role: lead

NCT07363473Not ApplicableNot Yet Recruiting

JOURNEY LVAD: JOURNEY Left Ventricular Assist Device

Role: lead

NCT06034028Not ApplicableActive Not Recruiting

J-Valve TF Early Feasibility Study

Role: lead

NCT03876964Unknown

J-Valve Compassionate Use

Role: lead

NCT03025971Not ApplicableCompleted

Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation

Role: lead

All 5 trials loaded